Cube Labs SpA (MIL:CUBE) Change In Inventory : €0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cube Labs SpA Change In Inventory?

Cube Labs SpA's change in inventory for the quarter that ended in Jun. 2023 was €0.00 Mil. It means Cube Labs SpA's inventory stayed the same from Dec. 2022 to Jun. 2023 .

Cube Labs SpA's change in inventory for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means Cube Labs SpA's inventory stayed the same from Dec. 2021 to Dec. 2022 .

Cube Labs SpA's Total Inventories for the quarter that ended in Jun. 2023 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cube Labs SpA's Days Inventory for the quarter that ended in Jun. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cube Labs SpA's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.00.

Cube Labs SpA Change In Inventory Historical Data

The historical data trend for Cube Labs SpA's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cube Labs SpA Change In Inventory Chart

Cube Labs SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Cube Labs SpA Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial			-	-	-	-	-

Cube Labs SpA Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Cube Labs SpA (MIL:CUBE) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cube Labs SpA's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0.891	*	365 / 2
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cube Labs SpA's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.891	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cube Labs SpA's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.752
	=	0.00

Cube Labs SpA Change In Inventory Related Terms

Thank you for viewing the detailed overview of Cube Labs SpA's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cube Labs SpA (MIL:CUBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Cube Labs SpA (MIL:CUBE) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Giulio Caccini, 1, Rome, ITA, 00186

Website

https://cube-labs.com

Cube Labs SpA operates as a venture builder that enables innovation in the healthcare technology space. The company is engaged in attracting sources of financing and providing entrepreneurial and operational support to the companies to develop healthcare technologies for the market.